Skip to main content
. 2023 Mar 27;11(4):1029. doi: 10.3390/biomedicines11041029

Table 2.

Immune cell subpopulations in all patients, patients with type 2 CRS, and CKD patients. Statistically significant differences between subgroups are highlighted in bold.

All Patients
(N = 63)
CRS Patients
(N = 39)
CKD Patients
(N = 24)
p-Value *
WBC (N) 7730 (IQR 6224–9495) 8360 (IQR 6730–9940) 7330 (IQR 6070–8830) 0.15
Monocytes (N) 500 (IQR 400–650) 600 (IQR 400–700) 500 (IQR 400–600) 0.06
Monocytes (%) 6.5 (5.4–7.9) 6.5 (IQR 5.4–8.1) 6.6 (IQR 5.3–7.8) 0.64
CD14++CD16- (N) 427 ± 167 450 ± 184 391 ± 132 0.14
CD14++CD16- (%) 81.4 ± 8.9 80.6 ± 10 82.6 ± 6.9 0.35
CD14++CD16+ (N) 38 (IQR 22–62) 41 (IQR 24–78) 35 (IQR 18–43) 0.04
CD14++CD16+ (%) 7.4 (IQR 5.4–11.2) 8 (IQR 5.6–12.0) 7.3 (IQR 4.7–9.6) 0.30
CD14+CD16++ (N) 25 (IQR 14–35) 22 (IQR 12–36) 25 (IQR 19–32) 0.80
CD14+CD16++ (%) 4.6 (IQR 3.0–6.7) 4.2 (IQR 2.7–6.6) 5.1 (IQR 4.0–6.7) 0.14
Lymphocytes (N) 1699 ± 658 1557 ± 691 1920 ± 545 0.03
Lymphocytes (%) 21.3 ± 8.7 18.7 ± 8.3 25.3 ± 8.0 0.002
T-lymphocytes (N) 1320 ± 500 1227 ± 510 1465 ± 455 0.06
T-lymphocytes (%) 79.6 ± 9.7 81.7 ± 8.7 76.3 ± 10.3 0.03
B-lymphocytes (N) 75 (IQR 37–140) 68 (IQR 31–104) 87 (IQR 58–163) 0.08
B-lymphocytes (%) 4.7 (2.9–8.3) 4.2 (IQR 2.2–9.0) 5.1 (IQR 3.4–7.9) 0.57
NK cells (N) 182 (124–328) 148 (IQR 103–258) 324 (IQR 179–368) 0.001
NK cells (%) 1.7 (IQR 8.2–18.3) 10.7 (IQR 7.1–16.6) 16.5 (IQR 11.2–19.6) 0.01
CD4+ T-Cells (N) 787 ± 312 732 ± 308 873 ± 304 0.08
CD4+ T-cells (%) 47.5 ± 10.6 48.6 ± 10.4 45.7 ± 10.9 0.30
CD8+ T-cells (N) 508 (IQR 353–750) 411 (IQR 224–720) 585 (IQR 447–786) 0.14
CD8+ T-cells (%) 29.9 (IQR 23.5–37.9) 28.5 (IQR 23.3–38.0) 31.5 (IQR 24.4–36.8) 0.73
Tregs (%) 2.4 (IQR 1.7–3.3) 2.7 (IQR 2.0–3.9) 2.0 (IQR 1.6–2.6) 0.03
T Regs (N) 37 (IQR 25–51) 36 (IQR 24–49) 40 (IQR 26–61) 0.94

Values are expressed in mean (± SD) or median (IQR 25–75th percentiles). CD, cluster of differentiation; NK, natural killer; N, number; Tregs, T regulatory cells. * p values refer to t-test significance for normal distribution variables, Mann–Whitney test significance for nonparametric variables, or chi-square test significance for categorical variables.